Early TKI-pharmokinetics and circulating tumor DNA (ctDNA) to predict outcome in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Early TKI-pharmokinetics and circulating tumor DNA (ctDNA) to predict outcome in patients with EGFR-mutated non-small cell lung cancer (NSCLC). |
| Type de publication | Journal Article |
| Year of Publication | 2017 |
| Auteurs | Bigot F, Pecuchet N, Blanchet B, Laurent-Puig P, Blons H, Goldwasser F, Boudou-Rouquette P, Auclin E, Oudard S, Fabre E |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 35 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/JCO.2017.35.15_suppl.11544 |